{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:56:04Z","timestamp":1774403764130,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100022896","name":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group","doi-asserted-by":"publisher","award":["2018 Below-the-belt"],"award-info":[{"award-number":["2018 Below-the-belt"]}],"id":[{"id":"10.13039\/501100022896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-04800-0","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:03:17Z","timestamp":1709560997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A phase 2 pilot study of water irrigation after transurethral resection of bladder tumor (WATIP) demonstrating safety, feasibility and activity"],"prefix":"10.1007","volume":"42","clinical-trial-number":[{"clinical-trial-number":"actrn12619000517178","registry":"10.18810\/anzctr"}],"author":[{"given":"Mo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchira","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Toniolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3357-1216","authenticated-orcid":false,"given":"Shomik","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"4800_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY Teoh","year":"2020","unstructured":"Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF et al (2020) Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol 78:893\u2013906","journal-title":"Eur Urol"},{"issue":"1","key":"4800_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"4","key":"4800_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0022-5347(17)66866-6","volume":"75","author":"F Hinman Jr","year":"1956","unstructured":"Hinman F Jr (1956) Recurrence of bladder tumors by surgical implantation. J Urol 75(4):695\u2013696","journal-title":"J Urol"},{"issue":"2","key":"4800_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"RJ Sylvester","year":"2016","unstructured":"Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S et al (2016) Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa\u2013pT1 urothelial carcinoma of the bladder: which patients benefit from the instillation? Eur Urol 69(2):231\u2013244","journal-title":"Eur Urol"},{"issue":"3","key":"4800_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","volume":"64","author":"N Perlis","year":"2013","unstructured":"Perlis N, Zlotta AR, Beyene J, Finelli A, Fleshner NE, Kulkarni GS (2013) Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol 64(3):421\u2013430","journal-title":"Eur Urol"},{"issue":"3","key":"4800_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447\u2013461","journal-title":"Eur Urol"},{"issue":"4","key":"4800_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR et al (2016) Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol 196(4):1021\u20131029","journal-title":"J Urol"},{"issue":"12","key":"4800_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/iju.14105","volume":"26","author":"SH Choo","year":"2019","unstructured":"Choo SH, Nishiyama H, Kitamura H, Chen CH, Pu YS, Lee HL et al (2019) Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: a web-based survey. Int J Urol 26(12):1121\u20131127","journal-title":"Int J Urol"},{"issue":"5","key":"4800_CR9","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.juro.2011.12.056","volume":"187","author":"MS Cookson","year":"2012","unstructured":"Cookson MS, Chang SS, Oefelein MG, Gallagher JR, Schwartz B, Heap K (2012) National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer. J Urol 187(5):1571\u20131576","journal-title":"J Urol"},{"issue":"2","key":"4800_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00345-013-1142-z","volume":"32","author":"J Palou-Redorta","year":"2014","unstructured":"Palou-Redorta J, Roupret M, Gallagher JR, Heap K, Corbell C, Schwartz B (2014) The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries. World J Urol 32(2):525\u2013530","journal-title":"World J Urol"},{"key":"4800_CR11","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1111\/ans.16740","volume":"91","author":"M Li","year":"2021","unstructured":"Li M, Toniolo J, Nandurkar R, Papa N, Lawrentschuk N, Davis ID et al (2021) Continuous bladder irrigation after transurethral resection of non-muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review. ANZ J Surg 91:2592\u20132598","journal-title":"ANZ J Surg"},{"issue":"2","key":"4800_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/iju.IJU_371_16","volume":"33","author":"P Bijalwan","year":"2017","unstructured":"Bijalwan P, Pooleri GK, Thomas A (2017) Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection. Indian J Urol 33(2):144\u2013148","journal-title":"Indian J Urol"},{"issue":"5","key":"4800_CR13","first-page":"301","volume":"46","author":"S Maekawa","year":"2000","unstructured":"Maekawa S, Suzuki H, Ohkubo K, Aoki Y, Okada T, Maeda H et al (2000) Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study. Hinyokika kiyo Acta urologica Japonica 46(5):301\u2013306","journal-title":"Hinyokika kiyo Acta urologica Japonica"},{"issue":"2","key":"4800_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/bju.13599","volume":"119","author":"T Onishi","year":"2017","unstructured":"Onishi T, Sugino Y, Shibahara T, Masui S, Yabana T, Sasaki T (2017) Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int 119(2):276\u2013282","journal-title":"BJU Int"},{"issue":"1\u20132","key":"4800_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/ans.17145","volume":"92","author":"R Nandurkar","year":"2022","unstructured":"Nandurkar R, Sluka P, Wardan H, Davis ID, Sengupta S (2022) Lytic effects of water on cancer cells: implications for post-operative irrigation. ANZ J Surg 92(1\u20132):157\u2013161","journal-title":"ANZ J Surg"},{"key":"4800_CR16","unstructured":"US Department of Health and Human Services (2017) https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-04800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:21:48Z","timestamp":1735852908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-04800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4800"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-04800-0","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ID Davis and S Sengupta are Board Directors (unpaid) of ANZUP trials group. ID Davis has been on advisory boards for Merck\/Pfizer, MSD, Eisai, Ipsen and Bristol Myers Squibb (All invoiced by and paid to ANZUP Cancer Trials Group). SS has been a speaker or advisor for Mundipharma, Abbvie, Ipsen, Janssen, MSD and the Eastern Melbourne Primary Health Networks (All honoraria donated directly into institutional research fund). No other author has any interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Undertaken with approval from Eastern Health Human Research Ethics Committee approval (E12-2018) and informed consent provided by participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal rights"}}],"article-number":"115"}}